CardioGenics Holdings Inc (CGNH)

Market Cap	14.29K
Revenue (ttm)	n/a
Net Income (ttm)	-980.79K
Shares Out	142.86M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,100
Average Volume	n/a
Open	0.0001
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	92.30
RSI	54.88
Earnings Date	n/a

About CardioGenics Holdings

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are u...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CGNH